Larimar Therapeutics, Inc. (LRMR)
NASDAQ
Market Cap
$447.88M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
13 of 809
Rank in Industry
10 of 445
Largest Insider Buys in Sector
LRMR Stock Price History Chart
LRMR Stock Performance
About Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Insider Activity of Larimar Therapeutics, Inc.
Over the last 12 months, insiders at Larimar Therapeutics, Inc. have bought $38.04M and sold $0 worth of Larimar Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Larimar Therapeutics, Inc. have bought $26.93M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Flynn James E (* Director by Deputization) — $1.42B. Hamilton Thomas Edward (director) — $999,996. THOMAS FRANK E (director) — $22,000.
The last purchase of 4,290,617 shares for transaction amount of $37.5M was made by Flynn James E (* Director by Deputization) on 2024‑02‑16.
List of Insider Buy and Sell Transactions, Larimar Therapeutics, Inc.
| 2024-02-16 | Flynn James E | * Director by Deputization | 4.29M 6.6831% | $8.74 | $37.5M | -38.46% | ||
| 2024-02-16 | Hamilton Thomas Edward | director | 57,208 0.0891% | $8.74 | $499,998 | -38.46% | ||
| 2024-02-14 | THOMAS FRANK E | director | 2,000 0.0064% | $11.00 | $22,000 | -34.20% | ||
| 2023-12-07 | Shankar Gopi | Chief Development Officer | 5,000 0.0119% | $3.73 | $18,662 | +100.83% | ||
| 2023-05-17 | BEN-MAIMON CAROLE | President and CEO | 5,000 0.0114% | $3.71 | $18,525 | +8.67% | ||
| 2023-05-17 | Celano Michael | Chief Financial Officer | 5,000 0.0115% | $3.73 | $18,632 | +8.67% | ||
| 2023-05-17 | Truitt Joseph | director | 2,750 0.0063% | $3.73 | $10,258 | +8.67% | ||
| 2022-09-16 | Flynn James E | 11.11M 49.2054% | $3.15 | $35M | +21.88% | |||
| 2022-09-16 | Hamilton Thomas Edward | director | 317,460 1.4059% | $3.15 | $999,999 | +21.88% | ||
| 2022-09-16 | BEN-MAIMON CAROLE | President and CEO | 31,746 0.1406% | $3.15 | $100,000 | +21.88% | ||
| 2022-09-16 | Celano Michael | Chief Financial Officer | 31,746 0.1406% | $3.15 | $100,000 | +21.88% | ||
| 2021-06-30 | Flynn James E | 685,710 3.341% | $8.75 | $6M | -2.39% | |||
| 2021-06-30 | Hamilton Thomas Edward | director | 56,710 0.2763% | $8.75 | $496,213 | -2.39% | ||
| 2018-06-28 | Sale | Hughes Thomas E. | See Remarks | 32,000 0.1034% | $10.00 | $320,000 | -47.50% | |
| 2018-03-07 | Sale | Hughes Thomas E. | See Remarks | 5,000 0.0194% | $10.00 | $50,000 | -8.25% | |
| 2017-10-13 | Heller Frances K | director | 20,000 0.0343% | $1.95 | $38,988 | +75.12% | ||
| 2017-07-11 | KIM DENNIS D | Chief Medical Officer | 20,000 0.037% | $1.70 | $33,900 | +63.77% | ||
| 2017-05-11 | KIM DENNIS D | Chief Medical Officer | 19,600 0.0729% | $4.40 | $86,240 | -12.41% | ||
| 2017-05-10 | KIM DENNIS D | Chief Medical Officer | 400 0.0014% | $4.40 | $1,760 | -15.92% | ||
| 2016-12-19 | Heller Frances K | director | 20,000 0.0742% | $3.23 | $64,580 | +16.61% |
Insider Historical Profitability
9.25%
| Flynn James E | 6151406 10.753% | $7.02 | 7 | 1 | <0.0001% | |
| Hamilton Thomas Edward | director | 564798 1.1561% | $7.02 | 3 | 0 | +21.88% |
| Shankar Gopi | Chief Development Officer | 5000 0.0114% | $7.02 | 1 | 0 | |
| THOMAS FRANK E | director | 2000 0.0046% | $7.02 | 1 | 0 | |
| BEN-MAIMON CAROLE | President and CEO | 266829 0.6077% | $7.02 | 2 | 0 | +15.27% |
| STARR KEVIN P | director | 210371 0.4791% | $7.02 | 0 | 1 | |
| Hughes Thomas E. | See Remarks | 125247 0.2853% | $7.02 | 2 | 4 | +20.01% |
| Celano Michael | Chief Financial Officer | 112746 0.2568% | $7.02 | 2 | 0 | +15.27% |
| Goldberg Avi Y. | director | 53734 0.1224% | $7.02 | 0 | 3 | |
| Heller Frances K | director | 47961 0.1092% | $7.02 | 4 | 0 | +29.04% |
| KIM DENNIS D | Chief Medical Officer | 21443 0.0488% | $7.02 | 3 | 3 | +11.81% |
| Allen Patricia L | Chief Financial Officer | 19793 0.0451% | $7.02 | 2 | 0 | +14.98% |
| Truitt Joseph | director | 2750 0.0063% | $7.02 | 1 | 0 | +8.67% |
| Secor Alicia | Chief Commercial Officer | 0 0% | $7.02 | 1 | 1 | +21.04% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Deerfield Management | $161.15M | 33.28 | 21.23M | +25.33% | +$32.57M | 3.12 | |
| RA Capital Management, L.P. | $45.88M | 9.48 | 6.05M | New | +$45.88M | 0.05 | |
| Janus Henderson | $30.46M | 6.3 | 4.02M | +52.25% | +$10.45M | 0.02 | |
| Blue Owl Capital Holdings Lp | $30.32M | 6.26 | 3.99M | +16.99% | +$4.4M | 5.71 | |
| Goldman Sachs | $25.94M | 5.36 | 3.42M | +2,452.98% | +$24.92M | 0.01 | |
| The Vanguard Group | $17.97M | 3.71 | 2.37M | +62.7% | +$6.93M | <0.0001 | |
| BlackRock | $17.75M | 3.67 | 2.34M | +40.22% | +$5.09M | <0.0001 | |
| Verition Fund Management Llc | $11.4M | 2.35 | 1.5M | -46.58% | -$9.94M | 0.12 | |
| Adage Capital Partners Gp L L C | $10.88M | 2.25 | 1.43M | +12.28% | +$1.19M | 0.02 | |
| Citadel Advisors LLC | $8.84M | 1.83 | 1.16M | +70.62% | +$3.66M | 0.01 | |
| Woodline Partners LP | $8.73M | 1.8 | 1.15M | +44.47% | +$2.69M | 0.08 | |
| Driehaus Capital Management LLC | $8.26M | 1.71 | 1.09M | New | +$8.26M | 0.08 | |
| Alger | $7.5M | 1.55 | 987,933 | +1,041.31% | +$6.84M | 0.04 | |
| Geode Capital Management | $6.6M | 1.36 | 869,383 | +34.22% | +$1.68M | <0.01 | |
| Mangrove Partners | $6.5M | 1.34 | 855,815 | +6.21% | +$379,500.01 | 0.07 | |
| Millennium Management LLC | $5.94M | 1.23 | 782,270 | New | +$5.94M | <0.01 | |
| Altium Capital Management Lp | $5.28M | 1.09 | 695,000 | New | +$5.28M | 2.45 | |
| DAFNA Capital Management, LLC | $4.98M | 1.03 | 656,373 | +102.66% | +$2.52M | 1.16 | |
| RTW Investments, LP | $4.93M | 1.02 | 650,000 | New | +$4.93M | 0.07 | |
| Assenagon Asset Management S.A. | $4.83M | 1 | 636,185 | New | +$4.83M | 0.01 | |
| State Street | $4.79M | 0.99 | 630,680 | +35.6% | +$1.26M | <0.0001 | |
| Alyeska Investment Group L P | $4.17M | 0.86 | 550,027 | New | +$4.17M | 0.03 | |
| Renaissance Technologies | $3.82M | 0.79 | 503,442 | +103.79% | +$1.95M | 0.01 | |
| Point72 Asset Management | $3.33M | 0.69 | 438,400 | -2.66% | -$91,080.00 | 0.01 | |
| Ikarian Capital LLC | $3.33M | 0.69 | 438,528 | -27.26% | -$1.25M | 0.95 | |
| Northern Trust | $2.24M | 0.46 | 295,422 | +10.11% | +$205,916.61 | <0.0001 | |
| Deutsche Bank | $2.06M | 0.43 | 271,924 | -0.17% | -$3,407.91 | <0.01 | |
| Atlas Venture Advisors Inc | $1.76M | 0.36 | 232,184 | -20.54% | -$455,400.11 | 0.35 | |
| Two Sigma | $1.6M | 0.33 | 210,472 | +518.51% | +$1.34M | <0.01 | |
| GHOST TREE CAPITAL LLC | $1.6M | 0.33 | 210,603 | New | +$1.6M | 0.52 | |
| Ubs Oconnor Llc | $1.54M | 0.32 | 202,783 | -36.61% | -$888,925.64 | 0.13 | |
| Two Sigma Advisers LP | $1.47M | 0.3 | 193,424 | +76.93% | +$638,318.93 | <0.01 | |
| Dimensional Fund Advisors | $1.33M | 0.28 | 175,744 | -9.96% | -$147,579.96 | <0.0001 | |
| Opaleye Management Inc | $1.32M | 0.27 | 174,413 | -72.03% | -$3.41M | 0.21 | |
| Caption Management Llc | $1.08M | 0.22 | 142,900 | New | +$1.08M | 0.03 | |
| Voya Investment Management LLC | $999,694.00 | 0.21 | 131,712 | +1,048.02% | +$912,613.94 | <0.01 | |
| Concentric Capital Strategies Lp | $936,037.00 | 0.19 | 123,325 | New | +$936,037.00 | 0.06 | |
| JPMorgan Chase | $902,352.00 | 0.19 | 118,887 | +96.5% | +$443,141.99 | <0.0001 | |
| Nuveen | $806,286.00 | 0.17 | 106,230 | +175.98% | +$514,131.61 | <0.0001 | |
| Boothbay Fund Management LLC | $780,965.00 | 0.16 | 102,894 | -20.82% | -$205,415.64 | 0.03 | |
| Marshall Wace | $757,391.00 | 0.16 | 99,788 | New | +$757,391.00 | <0.01 | |
| Hap Trading Llc | $751,289.00 | 0.16 | 98,984 | New | +$751,289.00 | 0.23 | |
| Qube Research & Technologies | $676,224.00 | 0.14 | 89,094 | New | +$676,224.00 | <0.01 | |
| BNY Mellon | $651,033.00 | 0.13 | 85,775 | -11.36% | -$83,406.61 | <0.0001 | |
| Bridgeway Capital Management | $641,355.00 | 0.13 | 84,500 | -29.29% | -$265,650.00 | 0.01 | |
| Charles Schwab | $630,038.00 | 0.13 | 83,009 | +12.54% | +$70,177.10 | <0.0001 | |
| Schonfeld Group | $614,031.00 | 0.13 | 80,900 | New | +$614,031.00 | <0.01 | |
| Jump Financial Llc | $593,576.00 | 0.12 | 78,205 | New | +$593,576.00 | 0.01 | |
| Simplex Trading Llc | $462,000.00 | 0.1 | 60,900 | New | +$462,000.00 | 0.01 | |
| Artia Global Partners Lp | $441,662.00 | 0.09 | 58,190 | New | +$441,662.00 | 0.11 |